Evidence map›Paper›PMID 32899112›Full record

ArticleJournal of personalized medicine2020

Induction of Micronuclei in Cervical Cancer Treated with Radiotherapy.

Daijiro Kobayashi, Takahiro Oike, Kazutoshi Murata, Daisuke Irie, Yuka Hirota, Hiro Sato, Atsushi Shibata, Tatsuya Ohno

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Effect of radiotherapy on the DNA cargo and cellular uptake mechanisms of extracellular vesicles.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Review
  4. Article
  5. Radiation Biomarkers: Silver Bullet, or Wild Goose Chase?Journal of personalized medicine · 2021
    Article
  6. The abscopal effect: a sense of DNA damage is in the air.The Journal of clinical investigation · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daijiro KobayashiDepartment of Radiation Oncology, Gunma Prefectural Cancer Center, Gunma 373-8550, Japan.ORCID 0000-0001-8887-9520
Takahiro OikeDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Kazutoshi MurataQST Hospital, National Institute for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
Daisuke IrieDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Yuka HirotaDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Hiro SatoDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Atsushi ShibataGunma University Initiative for Advanced Research (GIAR), Gunma University, Gunma 371-8511, Japan.ORCID 0000-0001-8912-6977
Tatsuya OhnoDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.ORCID 0000-0002-6703-3144

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micronuclei (MN) trigger antitumor immune responses via the cyclic GMP-AMP synthase-signaling effector stimulator of interferon genes (cGAS-STING) pathway. Radiotherapy induces MN in peripheral blood lymphocytes. However, data for solid tumors are lacking. Here, we analyzed MN post-radiotherapy in solid tumor samples. Tumor biopsy specimens were obtained from seven prospectively recruited patients with cervical cancer, before treatment and after receiving radiotherapy at a dose of 10 Gy (in five fractions). The samples were stained with 4',6-diamidino-2-phenylindole dihydrochloride, and 200 nuclei per sample were randomly identified and assessed for the presence of MN or apoptosis, based on nuclear morphology. The median number of MN-harboring nuclei was significantly greater in samples from patients treated with radiotherapy than in pre-treatment samples (151 (range, 16-327) versus 28 (range, 0-61);

Indexed as

abscopal effectcGASimmunotherapymicronucleiradiotherapySTINGuterine cervical cancer

Identifiers

PMID32899112
PMCPMC7563241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.